As this indigenous antibiotic becomes available, it carries with it the promise of a healthier future, a future where pneumonia and other drug-resistant infections ... Dec 05
Mylo has gained $17 million in its Series B funding round led by W Health Ventures along with ITC, Endiya Partners, Riverwalk Holdings, Alteria Capital, ... Apr 23
-Advertisements-